Published in Virology on January 01, 1973
Separate pathways of maturation of the major structural proteins of vesicular stomatitis virus. J Virol (1977) 4.03
Envelope proteins of vesicular stomatitis virus: effect of temperature-sensitive mutations in complementation groups III and V. J Virol (1974) 3.73
Influenza virus genome consists of eight distinct RNA species. Proc Natl Acad Sci U S A (1976) 3.14
Two functional domains of the influenza virus NS1 protein are required for regulation of nuclear export of mRNA. J Virol (1994) 2.54
Influenza virus NS1 protein enhances the rate of translation initiation of viral mRNAs. J Virol (1995) 2.16
Intracellular transport of influenza virus hemagglutinin to the apical surface of Madin-Darby canine kidney cells. J Cell Biol (1984) 2.08
Influenza virus NS1 protein stimulates translation of the M1 protein. J Virol (1994) 2.05
Regulation of a nuclear export signal by an adjacent inhibitory sequence: the effector domain of the influenza virus NS1 protein. Proc Natl Acad Sci U S A (1998) 1.94
Characterization of the mRNA of influenza virus. J Virol (1975) 1.71
Influenza HA subtypes demonstrate divergent phenotypes for cleavage activation and pH of fusion: implications for host range and adaptation. PLoS Pathog (2013) 1.64
Semliki Forest virus capsid protein associates with the 60S ribosomal subunit in infected cells. J Virol (1976) 1.57
Interaction cloning of NS1-I, a human protein that binds to the nonstructural NS1 proteins of influenza A and B viruses. J Virol (1996) 1.35
Carbohydrates of influenza virus. I. Glycopeptides derived from viral glycoproteins after labeling with radioactive sugars. J Virol (1977) 1.33
Dengue virus-induced modifications of host cell membranes. J Virol (1975) 1.33
Cell surface expression and orientation in membranes of the 44-amino-acid SH protein of simian virus 5. J Virol (1988) 1.27
Transient association of Semliki Forest virus capsid protein with ribosomes. J Virol (1977) 1.08
Time course of synthesis and assembly of influenza virus proteins. J Virol (1974) 1.05
Isolation and properties of an RNA polymerase from influenza virus-infected cells. J Virol (1973) 1.04
Isolation and characterization of cytoplasmic inclusions from influenza A virus-infected cells. J Virol (1978) 1.01
New aspects of influenza viruses. Clin Microbiol Rev (1992) 0.97
Influenza virus hemagglutinin containing an altered hydrophobic carboxy terminus accumulates intracellularly. J Virol (1984) 0.92
Disulfide bonding in influenza virus proteins as revealed by polyacrylamide gel electrophoresis. J Virol (1982) 0.85
Kinetics of utilization of Sendai virus RNA and protein in the process of virion assembly. J Virol (1976) 0.83
Expression of non-structural-1A binding protein in lung epithelial cells is modulated by miRNA-548an on exposure to influenza A virus. Virology (2013) 0.80
Interaction of avian influenza virus NS1 protein and nucleolar and coiled-body phosphoprotein 1. Virus Genes (2012) 0.80
Modulation of mouse mammary tumor virus production in the MJY-alpha cell line. J Virol (1978) 0.79
Molecular pathogenesis of H5 highly pathogenic avian influenza: the role of the haemagglutinin cleavage site motif. Rev Med Virol (2015) 0.78
Alterations of a mouse mammary tumor virus glycoprotein with interferon treatment. J Virol (1980) 0.77
Immunologic studies on the influenza A virus nonstructural protein NS1. J Exp Med (1982) 0.76
Characterization of temperature sensitive influenza virus mutants defective in neuraminidase. Virology (1974) 6.53
Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus. Science (1998) 5.83
Isolation of paramyxovirus glycoproteins. Association of both hemagglutinating and neuraminidase activities with the larger SV5 glycoprotein. Virology (1972) 4.05
An electron microscopic study of moderate and virulent virus-cell interactions of the parainfluenza virus SV5. Virology (1966) 4.03
Proteins of vesicular stomatitis virus and of phenotypically mixed vesicular stomatitis virus-simian virus 5 virions. J Virol (1971) 4.02
Influenza virus structural and nonstructural proteins in infected cells and their plasma membranes. Virology (1971) 3.96
The membrane structure of lipid-containing viruses. Biochim Biophys Acta (1974) 3.92
The three-dimensional structure of canine parvovirus and its functional implications. Science (1991) 3.87
Influenza type A virus neuraminidase does not play a role in viral entry, replication, assembly, or budding. J Virol (1995) 3.82
Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action. J Gen Virol (1976) 3.61
Influenza virus proteins. I. Analysis of polypeptides of the virion and identification of spike glycoproteins. Virology (1970) 3.58
Functional interactions between the fusion protein and hemagglutinin-neuraminidase of human parainfluenza viruses. J Virol (1992) 3.20
Human immunodeficiency virus envelope protein determines the site of virus release in polarized epithelial cells. Proc Natl Acad Sci U S A (1991) 3.18
Structure of the ribonucleoprotein of influenza virus. J Virol (1972) 3.11
Surface expression of viral glycoproteins is polarized in epithelial cells infected with recombinant vaccinia viral vectors. EMBO J (1986) 3.00
Assembly of animal viruses at cellular membranes. Annu Rev Microbiol (1988) 2.99
Functional interaction of paramyxovirus glycoproteins: identification of a domain in Sendai virus HN which promotes cell fusion. J Virol (1996) 2.63
Nucleocapsid protein subunits of simian virus 5, Newcastle disease virus, and Sendai virus. J Virol (1970) 2.58
Influenza virus hemagglutinin expression is polarized in cells infected with recombinant SV40 viruses carrying cloned hemagglutinin DNA. Cell (1983) 2.54
Isolation and properties of the helical nucleocapsid of the parainfluenza virus SV5. Proc Natl Acad Sci U S A (1967) 2.46
Proteins and glycoproteins of paramyxoviruses: a comparison of simian virus 5, Newcastle disease virus, and Sendai virus. J Virol (1971) 2.44
The M1 and M2 proteins of influenza A virus are important determinants in filamentous particle formation. Virology (1998) 2.43
Cytoplasmic domain truncation enhances fusion activity by the exterior glycoprotein complex of human immunodeficiency virus type 2 in selected cell types. J Virol (1992) 2.36
Location of the glycoprotein in the membrane of Sindbis virus. Nat New Biol (1971) 2.35
Cell fusion activity of the simian immunodeficiency virus envelope protein is modulated by the intracytoplasmic domain. Virology (1993) 2.23
Effects of glucosamine, 2-deoxyglucose, and tunicamycin on glycosylation, sulfation, and assembly of influenza viral proteins. Virology (1978) 2.13
Alpha/beta interferons potentiate virus-induced apoptosis through activation of the FADD/Caspase-8 death signaling pathway. J Virol (2000) 2.11
Polarity of influenza and vesicular stomatitis virus maturation in MDCK cells: lack of a requirement for glycosylation of viral glycoproteins. Proc Natl Acad Sci U S A (1979) 2.09
Truncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein alters the conformation of the external domain. J Virol (1994) 2.00
Peptides corresponding to the heptad repeat sequence of human parainfluenza virus fusion protein are potent inhibitors of virus infection. Virology (1996) 1.95
Basolateral maturation of retroviruses in polarized epithelial cells. J Virol (1983) 1.90
An electron microscopic study of the presence or absence of neuraminic acid in enveloped viruses. Virology (1970) 1.88
Identification of the spike proteins of Rous sarcoma virus. Virology (1971) 1.87
Protection against vaginal SIV transmission with microencapsulated vaccine. Science (1993) 1.86
Phenotypic mixing of envelope proteins of the parainfluenza virus SV5 and vesicular stomatitis virus. J Virol (1970) 1.85
Host cell dependence of viral morphology. Proc Natl Acad Sci U S A (1998) 1.78
Respiratory syncytial virus matures at the apical surfaces of polarized epithelial cells. J Virol (1995) 1.73
Murine model for evaluation of protective immunity to influenza virus. Vaccine (1993) 1.73
Association of the parainfluenza virus fusion and hemagglutinin-neuraminidase glycoproteins on cell surfaces. J Virol (1997) 1.71
Surface expression of influenza virus neuraminidase, an amino-terminally anchored viral membrane glycoprotein, in polarized epithelial cells. Mol Cell Biol (1985) 1.69
Regulation of the late events in flavivirus protein processing and maturation. Virology (1993) 1.68
Release of simian virus 40 virions from epithelial cells is polarized and occurs without cell lysis. J Virol (1989) 1.66
An electron microscopic study of single-cycle infection of chick embryo fibroblasts by influenza virus. Virology (1969) 1.65
The human and simian immunodeficiency virus envelope glycoprotein transmembrane subunits are palmitoylated. Proc Natl Acad Sci U S A (1995) 1.65
The P gene of human parainfluenza virus type 1 encodes P and C proteins but not a cysteine-rich V protein. J Virol (1991) 1.64
Parainfluenza virus surface projections: glycoproteins with haemagglutinin and neuraminidase activities. J Gen Virol (1971) 1.62
Expression of the human immunodeficiency virus envelope glycoprotein is restricted to basolateral surfaces of polarized epithelial cells. J Virol (1989) 1.59
The human immunodeficiency virus type 1 envelope glycoprotein precursor acquires aberrant intermolecular disulfide bonds that may prevent normal proteolytic processing. Virology (1990) 1.57
Spin-labeled electron spin resonance study of the lipid-containing membrane of influenza virus. Proc Natl Acad Sci U S A (1971) 1.57
Host cell- and virus strain-dependent differences in oligosaccharides of hemagglutinin glycoproteins of influenza A viruses. Virology (1979) 1.56
A specific labeling procedure for proteins on the outer surface of membranes. J Biol Chem (1972) 1.55
Membrane interactions of synthetic peptides corresponding to amphipathic helical segments of the human immunodeficiency virus type-1 envelope glycoprotein. J Biol Chem (1992) 1.53
Effects of cytoplasmic domain length on cell surface expression and syncytium-forming capacity of the simian immunodeficiency virus envelope glycoprotein. Virology (1994) 1.52
Delayed appearance of pseudotypes between vesicular stomatitis virus influenza virus during mixed infection of MDCK cells. J Virol (1981) 1.52
Cytosolic domain of the human immunodeficiency virus envelope glycoproteins binds to calmodulin and inhibits calmodulin-regulated proteins. J Biol Chem (1993) 1.50
Proteolytic cleavage of subunits of the nucleocapsid of the paramyxovirus simian virus 5. J Virol (1974) 1.49
Effect of antibody to neuraminidase on the maturation and hemagglutinating activity of an influenza A2 virus. J Virol (1969) 1.47
Preliminary X-ray crystallographic analysis of canine parvovirus crystals. J Mol Biol (1988) 1.46
Expression of herpes simplex virus glycoproteins in polarized epithelial cells. J Virol (1986) 1.46
Virus infection of polarized epithelial cells. Adv Virus Res (1993) 1.44
Induction of CD4(+) T-cell-independent immunoglobulin responses by inactivated influenza virus. J Virol (2000) 1.44
Differential effect of monensin on enveloped viruses that form at distinct plasma membrane domains. J Cell Biol (1981) 1.44
Proteolytic cleavage of the hemagglutinin polypeptide of influenza virus. Function of the uncleaved polypeptide HA. Virology (1973) 1.43
Entry and release of measles virus are polarized in epithelial cells. Virology (1995) 1.43
Glycopeptide components of influenza viral glycoproteins. Virology (1978) 1.42
Hemagglutination-inhibition: rapid assay for neuraminic acid-containing viruses. J Virol (1974) 1.42
Expression of the influenza A virus M2 protein is restricted to apical surfaces of polarized epithelial cells. J Virol (1992) 1.42
Processing of the intracellular form of the west Nile virus capsid protein by the viral NS2B-NS3 protease: an in vitro study. J Virol (1994) 1.42
An infectious clone of the West Nile flavivirus. Virology (2001) 1.42
Effects of hexose starvation and the role of sialic acid in influenza virus release. Virology (1983) 1.41
Oligomerization of the hydrophobic heptad repeat of gp41. J Virol (1995) 1.38
Polarized expression of a chimeric protein in which the transmembrane and cytoplasmic domains of the influenza virus hemagglutinin have been replaced by those of the vesicular stomatitis virus G protein. Proc Natl Acad Sci U S A (1986) 1.37
The length of the helical nucleocapsid of Newcastle disease virus. Virology (1967) 1.36
Effects of antibody to the influenza A virus M2 protein on M2 surface expression and virus assembly. Virology (1995) 1.35
Human immunodeficiency virus type 1 envelope glycoprotein is modified by O-linked oligosaccharides. J Virol (1994) 1.35
Analysis of the cell fusion activities of chimeric simian immunodeficiency virus-murine leukemia virus envelope proteins: inhibitory effects of the R peptide. J Virol (1996) 1.35
Vectorial release of poliovirus from polarized human intestinal epithelial cells. J Virol (1993) 1.34
Role of actin microfilaments in Black Creek Canal virus morphogenesis. J Virol (1998) 1.34
Entry of simian virus 40 is restricted to apical surfaces of polarized epithelial cells. Mol Cell Biol (1988) 1.33
Chimeric influenza virus hemagglutinin containing either the NH2 terminus or the COOH terminus of G protein of vesicular stomatitis virus is defective in transport to the cell surface. Proc Natl Acad Sci U S A (1984) 1.33
Analysis of the murine leukemia virus R peptide: delineation of the molecular determinants which are important for its fusion inhibition activity. J Virol (1997) 1.31
The nucleic acid of the parainfluenza virus SV5. Virology (1968) 1.30
Assembly and polarized release of Punta Toro virus and effects of brefeldin A. J Virol (1991) 1.30
Effect of cytochalasin B on the maturation of enveloped viruses. J Exp Med (1979) 1.28
Distinct carbohydrate components of influenza virus glycoproteins in smooth and rough cytoplasmic membranes. Virology (1973) 1.28
Human immunodeficiency virus type 2 envelope glycoprotein: differential CD4 interactions of soluble gp120 versus the assembled envelope complex. Virology (1992) 1.28
Assembly of SIV virus-like particles containing envelope proteins using a baculovirus expression system. Virology (1995) 1.26
Vesicular stomatitis virus G protein acquires pH-independent fusion activity during transport in a polarized endometrial cell line. J Virol (1999) 1.25
Virion RNA species of the arenaviruses Pichinde, Tacaribe, and Tamiami. J Virol (1978) 1.24
Studies on pneumonia virus of mice (PVM) in cell culture. II. Structure and morphogenesis of the virus particle. J Exp Med (1967) 1.24
Nucleotide sequence conservation at the 3' termini of the virion RNA species of New World and Old World arenaviruses. Virology (1982) 1.24
The organization of the proteins of vesicular stomatitis virions: labeling with pyridoxal phosphate. Virology (1975) 1.23
Oral immunization with influenza virus in biodegradable microspheres. J Infect Dis (1993) 1.23
Basolateral expression of a chimeric protein in which the transmembrane and cytoplasmic domains of vesicular stomatitis virus G protein have been replaced by those of the influenza virus hemagglutinin. J Biol Chem (1987) 1.23
The formation of poliovirus particles in association with the RNA replication complexes. J Gen Virol (1973) 1.23
Effect of membrane protein on lipid bilayer structure: a spin-label electron spin resonance study of vesicular stomatitis virus. Biochemistry (1976) 1.22
Formation of the flavivirus envelope: role of the viral NS2B-NS3 protease. J Virol (1995) 1.22
Nonpolarized expression of a secreted murine leukemia virus glycoprotein in polarized epithelial cells. Cell (1986) 1.21
Sulfated components of enveloped viruses. J Virol (1975) 1.21
Antibody-resistant spread of vesicular stomatitis virus infection in cell lines of epithelial origin. J Virol (1980) 1.21